Holiday Deals Start Now! Save $150 on CEFALY DUAL & 10% on Electrodes

×

CEFALY Technology Launches Buy Back/trade In Program For Customers In Us And Canada

May 21, 2020

The Buy Back allows CEFALY users in the U.S. and Canada to trade up their device and receive a discount for a smaller, sleeker, device with two migraine treatment programs, rechargeable battery, and a renewed 60-day money back guarantee.

The Buy Back allows CEFALY users to trade up their device for a smaller, sleeker, device with two migraine treatment programs, rechargeable battery, and a renewed 60-day money back guarantee.

Click here to view the full press release on PRNewswire.

NEW YORK, March 17, 2020 _ CEFALY, the first device of its kind to receive FDA Cleared (prescription required) for migraine headaches announced a Buy Back program today where customers in the United States and Canada may return their original CEFALY 1 device (C1) and receive a discount off the purchase of a CEFALY DUAL device.

The new CEFALY DUAL device is small and sleek in comparison to its older model, which uses bands along the sides to create room for batteries. The newest device is palm-sized, more portable, and uses a battery that is rechargeable via USB.

The CEFALY DUAL offers two distinct treatment options — a 60-minute ACUTE setting that serves as an abortive treatment for pain relief at the onset of a migraine, which is clinically proven to stop or reduce migraine pain during an attack; and a 20-minute PREVENT setting for daily use to help prevent future episodes. The Buy Back program offers users already accustomed to the CEFALY treatment an opportunity to swap their device and pay the difference to upgrade to a the CEFALY DUAL. The new device will again come with a renewed 60-day money back guarantee.

“We are excited to provide a program where customers already familiar with the many benefits of CEFALY can upgrade their existing device and benefit from the latest in migraine treatment technology and a new compact device with two program options,” said Jennifer Trainor-McDermott, CEO with CEFALY Technology.

CEFALY has rapidly become a global brand, widely recognized among the migraine community, which is estimated to be around 1 billion worldwide1. The non-invasive device is placed on the forehead to stimulate and desensitize the area research identifies as a center for migraine pain, the Trigeminal nerve. Since CEFALY is not a drug, it can be used as a standalone option or with an existing treatment. Customers who use the device consistently show a decrease in migraine days and a reduced use of migraine medication.

To participate in the Buy Back program eligible users in the United States will receive a $150 USD discount code to purchase a CEFALY DUAL device. For more information visit: https://www.cefaly.us/en/cefaly1-trade-in-program. In Canada, eligible users will receive a CA$50 discount code to purchase a CEFALY DUAL device. For more information visit: https://www.cefaly.com/en-ca/cefaly-c1-device-trade-in-program

About CEFALY Technology

CEFALY Technology is a global company that has been transforming migraine treatment since 2008, when the CEFALY device was introduced. CEFALY Technology’s mission is to solve the persistent problem of migraine through advanced therapeutic innovations.

For more information about CEFALY Technology visit: https://www.cefaly.us.

For more information on purchasing CEFALY in Canada visit: https://www.cefaly.com/en-ca.

Sources

1 Migraine facts. American Migraine Foundation website. Accessed March 16, 2020.